Company, Human health, Animal health
Pleased to share that Revatis sa's european patent EP3610001, covering our method for obtaining differentiated cells from muslce-derived progenitor cells, has been granted and registered with unitary effect.
The milestone strenghtens the protection of our core technology platform.
A sincere thank you to the Revatis team who contributed to this achievement.
#stemcells #bioengineering #tissueengineering #regenerativemedicine #cellandgenetherapy